BD hunting "plug in" acquisitions
BD is on the lookout for more acquisitions with firms it can easily “plug in” to its business.
BD is on the lookout for more acquisitions with firms it can easily “plug in” to its business.
Indian pharma firm Cipla will invest INR5bn ($90.5m) in three new API manufacturing plants.
Biopharma manufacturers are putting their supply chains at risk by failing to prepare for emergencies, according to a new study by Best Practices, LLC.
The luggage Team USA took to the London 2012 Olympics was lighter than that carried to previous tournaments thanks to a technology provided by GE Healthcare.
Parexel may be willing to act as a matchmaker for the small and midsized developers that work with its new BioPharm unit according to COO Mark Goldberg.
Outsourcing-Pharma.com presents the low down on new services forged by partnerships and M&A (mergers and acquisitions), including a molecular biology offering for Quotient, Onyx’s added purification and separation capabilities, and Accenture’s new...
DSM will conduct further cost cutting at its Pharma business as part of a wider ‘profit improvement initiative’ that will see it cut 1,000 jobs over the next 18 months.